The Nasik facility began operations in the year 1983. It is Glenmark’s first manufacturing facility.

Today the facility manufactures more than 200 products catering to the bulk of the demand for solid orals, liquid orals, and external creams and powders across 71 markets in Asia [including India], Africa, CIS/Russia and Latin America This state-of-the-art facility has been approved by WHO-GMP and several international regulators across the semi-regulated markets.